← Open Payments lookup

OLOLADE ADEKOYA: Open Payments

NPI 1144686569 · GLEN BURNIE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$3,394 in 101 payments from 18 companies in 2025. Trend: 2023 $46 · 2024 $2,056 · 2025 $3,394

Food & beverage: $3,394
CompanyPaymentsAmount
ABBVIE INC.24$790
Otsuka America Pharmaceutical, Inc.10$512
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)16$479
Neurocrine BioSciences, Inc.4$223
Axsome Therapeutics, Inc.8$218
Supernus Pharmaceuticals, Inc.6$198
E.R. Squibb & Sons, L.L.C.7$184
Lundbeck LLC8$181
Janssen Pharmaceuticals, Inc1$118
Indivior Inc.3$117

Products named: VRAYLAR, CAPLYTA, REXULTI, ABILIFY MAINTENA, INGREZZA, Auvelity, Qelbree, COBENFY.

Industry payments across MD — which companies pay providers there.